Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

MARIS Study; Mediterranean Approach to Reduce Insulin-Resistance Study

This study has been completed.
Sponsor:
Collaborators:
Netherlands Heart Foundation
Unilever R&D
Information provided by:
Wageningen University
ClinicalTrials.gov Identifier:
NCT00405197
First received: November 28, 2006
Last updated: December 10, 2007
Last verified: December 2007